Unichem Laboratories balance sheet

As of Mar 2026

Total assets: ₹3,737cr+4.7% on Mar 2025
Shareholders' equity: ₹2,717cr+10.9% on Mar 2025
Total debt: ₹469cr+9.0% on Mar 2025
Cash and investments: ₹289cr+223.2% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,204	1,279	1,194	1,255
	100	30.7	123	147
	1.6	1.6	1.5	1.5
	7.3	18.7	0.0	0.0
	0.0	0.0	0.0	0.2
	0.1	0.1	0.1	0.1
	8.6	8.3	5.9	6.3
	8.7	8.4	6.0	6.6
	30.6	25.8	6.8	10.1
	185	167	140	180
	1,537	1,531	1,472	1,601
	975	989	705	625
	0.0	0.0	1.3	1.5
	829	779	610	589
	289	89.6	151	184
	5.2	28.1	3.4	1.6
	0.1	0.1	0.0	0.1
	4.4	4.8	0.2	1.7
	1,128	901	766	777
	94.6	139	223	186
	2,197	2,029	1,694	1,588
	3.3	8.5	3.3	3.4
	3,737	3,569	3,169	3,193
Equity
	14.1	14.1	14.1	14.1
	2,703	2,437	2,348	2,421
	2,717	2,451	2,362	2,435
	2,717	2,451	2,362	2,435
Liabilities
	39.1	60.8	38.2	63.6
	26.0	25.2	24.2	11.5
	65.1	86.0	62.4	75.1
	28.6	37.9	35.8	41.9
	39.9	0.0	0.0	0.0
	0.4	3.0	0.9	1.1
	134	127	99.0	118
	430	369	181	234
	357	403	299	291
	65.0	55.3	33.4	50.8
	851	827	514	575
	4.7	138	136	12.0
	—	4.3	2.2	0.5
	29.9	23.0	56.1	51.9
	886	992	708	640
	1,020	1,119	807	758
	3,737	3,569	3,169	3,193
Trade payables — MSME split
	15.0	7.7	—	—
	342	395	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

UNICHEMLAB₹488.80

Unichem Laboratories Limited

· Pharma & Health

₹ CrorePeersGUFICBIO RPGLIFE GUJTHEM SMSPHARMA ORCHPHARMA INDSWFTLAB SOLARA FDCMcap ₹3,441 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,255.1	1,194.4	1,279.3	1,203.7	1,203.7
+ Capital Work-in-Progress	147.5	122.7	30.7	100.1	100.1
+ Goodwill	1.5	1.5	1.6	1.6	1.6
+ Other Intangibles	0.0	0.0	18.7	7.3	7.3
+ Non-current Investments	0.2	0.0	0.0	0.0	0.0
+ Long-term Loans	0.1	0.1	0.1	0.1	0.1
+ Other Non-current Financial Assets	6.3	5.9	8.3	8.6	8.6
Non-current Financial Assets	6.6	6.0	8.4	8.7	8.7
+ Deferred Tax Assets	10.1	6.8	25.8	30.6	30.6
+ Other Non-current Assets	180.3	140.3	167.0	184.9	184.9
Total Non-current Assets	1,601.2	1,471.8	1,531.5	1,536.9	1,536.9
Current Assets
+ Inventories	625.2	704.7	988.7	975.0	975.0
+ Current Investments	1.5	1.3	0.0	0.0	0.0
+ Trade Receivables	588.6	610.4	778.8	828.6	828.6
+ Cash & Cash Equivalents	183.8	150.9	89.6	289.5	289.5
+ Other Bank Balances	1.6	3.4	28.1	5.2	5.2
+ Short-term Loans	0.1	0.0	0.1	0.1	0.1
+ Other Current Financial Assets	1.7	0.2	4.8	4.4	4.4
Current Financial Assets	777.3	766.3	901.3	1,127.8	1,127.8
+ Other Current Assets	186.0	223.2	139.4	94.6	94.6
Total Current Assets	1,588.5	1,694.2	2,029.5	2,197.3	2,197.3
+ Assets Held for Sale	3.4	3.3	8.5	3.3	3.3
Total Assets	3,193.0	3,169.3	3,569.4	3,737.4	3,737.4
Equity
+ Equity Share Capital	14.1	14.1	14.1	14.1	14.1
+ Other Equity / Reserves	2,421.2	2,348.3	2,436.5	2,703.4	2,703.4
Equity — Owners of Parent	2,435.3	2,362.4	2,450.6	2,717.4	2,717.4
Total Equity	2,435.3	2,362.4	2,450.6	2,717.4	2,717.4
Liabilities
+ Borrowings — Non-current	63.6	38.2	60.8	39.1	39.1
+ Other Non-current Financial Liab	11.5	24.2	25.2	26.0	26.0
Non-current Financial Liabilities	75.1	62.4	86.0	65.1	65.1
+ Provisions — Non-current	41.9	35.8	37.9	28.6	28.6
+ Deferred Tax Liabilities	0.0	0.0	0.0	39.9	39.9
+ Other Non-current Liabilities	1.1	0.9	3.0	0.4	0.4
Non-current Liabilities	118.1	99.0	126.8	134.1	134.1
+ Borrowings — Current	233.7	180.9	369.2	429.7	429.7
+ Trade Payables	290.7	299.4	402.6	356.6	356.6
+ Other Current Financial Liab	50.8	33.4	55.3	65.0	65.0
Current Financial Liabilities	575.2	513.7	827.0	851.3	851.3
+ Provisions — Current	12.0	135.9	137.6	4.7	4.7
+ Current Tax Liabilities	0.5	2.2	4.3	—	—
+ Other Current Liabilities	51.9	56.1	23.0	29.9	29.9
Current Liabilities	639.6	707.9	992.0	885.9	885.9
Total Liabilities	757.7	806.9	1,118.8	1,020.0	1,020.0
Total Equity & Liabilities	3,193.0	3,169.3	3,569.4	3,737.4	3,737.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	7.7	15.0	15.0
+ Dues to Other Creditors — Current	—	—	394.9	341.7	341.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.